Deals
Icahn Builds Small Position in Drugmaker Allergan
- Size of stake, motivation behind investment is unknown
- Allergan under fire for planning to spin off two units
Carl Icahn
Photographer: Victor J. Blue/Bloomberg
This article is for subscribers only.
Carl Icahn has built a small position in Allergan Plc, according to people familiar with the matter, as the drugmaker plans to spin off its women’s health and antibiotic divisions.
Icahn’s motivation and the size of his investment remain unclear, said the people, who asked not to be identified because the matter is private. Icahn previously held a position in Allergan, disclosing a stake in 2016 that was sold in the first quarter of 2017, according to data compiled by Bloomberg.